Take an In-Depth Look At Our Pipeline
We’re rapidly developing innovative solutions to meet some of society’s most difficult health care challenges.
Find Out Why We’re So Focused On Neurology and Oncology
And learn how we’re spearheading work in immuno-oncology, dementia and Alzheimer’s disease treatments, sleep-wake disorders and more.
30+
That’s How Many Years We’ve Been Investing Our Research Dollars — And Our Hearts and Souls — In Neurology and Oncology R&D.
Learn About Clinical Trials That Could Lead To Breakthroughs
We’re evaluating potential new therapies for a variety of cancers and neurological disorders.
Discover New Frontiers of Neurology and Oncology Science
We've established a Discovery Center with a bold approach to pushing the boundaries of science in search of life-changing solutions.
Research & Development
Our innovation begins in our research and development organization, which we call Deep Human Biology Learning (DHBL). The DHBL approach to science leverages our unique strengths in complex chemistry and disease expertise along with our advances in human genetics, biotechnologies and digital technologies.
Seemingly different pathological conditions that occur in a wide variety of human diseases can have similar causes and common mechanisms, so it’s vital that our approach to R&D encourages cross-pollination, collaboration and communication among all our scientists.
Watch an interactive panel discussion with Drs. Lynn Kramer, Chief Clinical Officer, DHBL, Shobha Dhadda, Chief Clinical Science and Operations Officer, and Janna Hutz, President of Eisai’s Center for Genetics Guided Dementia Discovery and Head of Neurology Discovery, in which they discuss how we’re revolutionizing drug discovery through DHBL with Britt Whittmore, Executive Producer, STAT Brand Studio.